New Diabetic Vascular Disease Research at MU

A University of Missouri research team is being awarded grants to study vascular disease in Type 2 diabetics.

The more than $6 million National Institutes of Health grants will allow the team to research how vascular disease develops in people with Type 2 diabetes.

The team received two separate grants, one will test a plant-based supplement that inhibits an enzyme known as ADAM17, the other grant-funded research will target an enzyme that disrupts cell structures in the vessels that sense blood flow.

The research will be done in the new NextGen Precision Health building, set to open in October.